Patients who underwent an MRI scan were not exposed to any ionizing radiation, which is present in PET-CT scans and poses the risk of developing into secondary cancer later in life.
In the study, the PET-CT scans detected 163 of 174 malignant lesions, and the MRI scans detected 158.
Researchers suggest using whole-body diffusion-weighted MRI scans to stage cancerous tumors may help prevent long-term risks of radiation exposure from PET-CT scans.
More Articles on Medical Devices:
FDA Approves Magellan 6Fr Robotic Catheter
‘Poka-Yoke’: Applying Japanese Design Concepts to Minimize Device Errors
FDA Clears IMRIS’ VISIUS Surgical Theatre Imaging System
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
